Plasma Aβ <sub>42</sub> /Aβ <sub>40</sub> is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum

Lumipulse plasma amyloid beta (Aβ)<sub>42</sub>/Aβ<sub>40</sub> exhibited high accuracy in detecting amyloid positivity. Plasma amyloid-positive (Aβ+) individuals exhibited stability of Aβ<sub>42</sub>/Aβ<sub>40</sub> over time. Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> predicted future cognitive decline across the Alzheimer's disease (AD) spectrum. Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> was sensitive to memory and tau burden in clinically unimpaired older adults.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-23
DOI
https://doi.org/10.1002/alz.14442
Citations
24
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
7.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Aβ 42 /Aβ 40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum

Yann Le Guen, Robert R. Butler, Nicole K. Corso, America Romero et al.
24 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
7.84
article

Plasma Aβ 42 /Aβ 40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum

Yann Le Guen, Robert R. Butler, Nicole K. Corso, America Romero, Lü Tian, Anthony D. Wagner, Irina A. Skylar-Scott, Frank M. Longo, Kyan Younes, Geoffrey A. Kerchner, Guido Davidzon, Carolyn Fredericks, Javier Ramos Benitez, Tony Wyss‐Coray, Katrin I. Andreasson, Igor Feinstein, Maya Yutsis, Edward Norman Wilson, Karly Alex Cody, Kathleen L. Poston, Divya Channappa, Sharon J. Sha, Gayle K. Deutsch, Jaime Mendiola, Michael D. Greicius, Alexandra N. Trelle, Elizabeth C. Mormino, Marian Shahid, Christina B. Young, Victor W. Henderson, Hillary Vossler, Amanda Smith, Jennifer Park, Michelle S. Swarovski, Kelly Chau
article en
24 citations

Abstract

Lumipulse plasma amyloid beta (Aβ)<sub>42</sub>/Aβ<sub>40</sub> exhibited high accuracy in detecting amyloid positivity. Plasma amyloid-positive (Aβ+) individuals exhibited stability of Aβ<sub>42</sub>/Aβ<sub>40</sub> over time. Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> predicted future cognitive decline across the Alzheimer's disease (AD) spectrum. Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> was sensitive to memory and tau burden in clinically unimpaired older adults.

Alzheimer s & DementiaVol. 21(2)
Roche (Switzerland) (CH), Neurosciences Institute (US), Yale University (US), Stanford Health Care (US), Stanford Medicine (US), University Radiology (US), Stanford University (US)
Alzheimer's Association, Jean Perkins Foundation, National Institutes of Health, National Institute on Aging
No poverty
Openalex Percentile: Top 2%
Alzheimer's disease research and treatments
7.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.